{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:43:07Z","timestamp":1791852187740,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.029","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T12:38:51Z","timestamp":1469536731000},"page":"4579-4585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO\u00ae in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study"],"prefix":"10.1016","volume":"34","author":[{"given":"Jakob P.","family":"Cramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Dubischar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd D.","family":"Burchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Westritschnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2016.07.029_b0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.029_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1501.080311","article-title":"Past, present, and future of Japanese encephalitis","volume":"15","author":"Erlanger","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.029_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.ento.54.110807.090510","article-title":"Ecology and geographical expansion of Japanese encephalitis virus","volume":"54","author":"van den Hurk","year":"2009","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.vaccine.2016.07.029_b0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidemiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.029_b0025","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis\u2013within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.029_b0030","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4269\/ajtmh.2010.09-0676","article-title":"Japanese encephalitis in travelers from non-endemic countries, 1973\u20132008","volume":"82","author":"Hills","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.07.029_b0035","unstructured":"World Tourism Organization. Yearbook of tourism statistics dataset; 2013."},{"issue":"9602","key":"10.1016\/j.vaccine.2016.07.029_b0040","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"issue":"39","key":"10.1016\/j.vaccine.2016.07.029_b0045","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.vaccine.2010.07.040","article-title":"Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up","volume":"28","author":"Dubischar-Kastner","year":"2010","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2016.07.029_b0050","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1016\/j.vaccine.2011.08.117","article-title":"Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R))","volume":"29","author":"Schuller","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.029_b0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol"},{"issue":"21","key":"10.1016\/j.vaccine.2016.07.029_b0060","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2004.11.040","article-title":"Review on flavivirus vaccine development: proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26\u201327 April 2004, Bangkok, Thailand","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2016.07.029_b0065","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.029_b0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.029_b0075","unstructured":"Intercell AG. Clinical study report IC51-310; 2008."},{"issue":"7","key":"10.1016\/j.vaccine.2016.07.029_b0080","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1080\/21645515.2015.1045167","article-title":"A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix in healthy adults","volume":"11","author":"Van Der Meeren","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2016.07.029_b0085","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1080\/21645515.2015.1039758","article-title":"Characterization of an age-response relationship to GSK\u2019s recombinant hepatitis B vaccine in healthy adults: an integrated analysis","volume":"11","author":"Van Der Meeren","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2016.07.029_b0090","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly\u2013results from an observational study","volume":"9","author":"Jilkova","year":"2009","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.029_b0095","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/infdis\/jir172","article-title":"Dose-sparing H5N1 A\/Indonesia\/05\/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study","volume":"203","author":"Langley","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.029_b0100","unstructured":"Pasteur S. Prescribing information; 271\/371 Fluzone; 372 Fluzone high-dose; 390 Fluzone Intradermal; 2011."},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2016.07.029_b0105","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/S0264-410X(03)00399-2","article-title":"Immunogenicity of combined hepatitis A and B vaccine in elderly persons","volume":"21","author":"Wolters","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.029_b0110","unstructured":"European Medicine Agency. IXIARO summary of product characteristics; 2015."},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.029_b0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.vaccine.2011.11.061","article-title":"Immunogenicity of delayed TBE-vaccine booster","volume":"30","author":"Askling","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.029_b0120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.vaccine.2012.12.075","article-title":"Factors associated with seroimmunity against tick borne encephalitis virus 10years after booster vaccination","volume":"31","author":"Paulke-Korinek","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.029_b0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1708-8305.2006.00001.x","article-title":"Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly","volume":"13","author":"D\u2019Acremont","year":"2006","journal-title":"J Travel Med"},{"issue":"48","key":"10.1016\/j.vaccine.2016.07.029_b0130","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.vaccine.2008.08.056","article-title":"Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T03:20:59Z","timestamp":1536549659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":26,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16306120"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO\u00ae in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}